Navigation Links
Non-Safety-Related Voluntary Recall of a Limited Portion of DAYTRANA(TM) (Methylphenidate Transdermal System) Patches Announced
Date:6/9/2008

PHILADELPHIA, June 9 /PRNewswire-FirstCall/ -- Shire Limited (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced today a voluntary recall of two (2) lots of the ADHD patch DAYTRANA (lots 2750211 and 2764111). Shire is taking this action because some DAYTRANA patches do not meet their release liner removal specification, and as a result, patients and caregivers could have difficulties removing the liners. This voluntary recall is not due to safety issues.

Because this voluntary recall is not due to product safety issues, all DAYTRANA patches, including those in the lots listed above, can continue to be used unless the release liner cannot be removed, or the patches are damaged while being opened.

The current supply levels of DAYTRANA should be sufficient to ensure that patients can continue to have their DAYTRANA prescriptions filled at their local pharmacy. Noven Pharmaceuticals, Inc. continues to manufacture and Shire continues to promote this product in the United States.

Shire will continue its ongoing quality assurance monitoring and data analysis of DAYTRANA, and may implement future additional voluntary actions. Shire and Noven continue to actively pursue enhancements to this product, and to work closely with the United States Food and Drug Administration (FDA) to implement changes that may enhance the usability of DAYTRANA.

Physicians, patients and caregivers who have questions regarding DAYTRANA should call Shire's DAYTRANA customer service line at 1-800-828-2088, option 1, and pharmacists should call 1-888-879-8218.

DAYTRANA is licensed globally to Shire by Noven. Shire and Noven have notified the FDA of this voluntary recall.

Notes to editors

Important Safety Information

Tell your doctor about any heart conditions, including structural abnormalities, your child or a family member may have. Inform your doctor immediately if the child develops symptoms that sugges
'/>"/>

SOURCE Shire Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets
2. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
3. Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products
4. Application for Listing of Shire Limited Ordinary Shares
5. Limited transparency in federal nanotech research may hamper development
6. Alimera Sciences, pSivida Limited Amend Medidur(TM) FA Collaboration Agreement
7. Daval International Limited Gains Approval for Phase IIB Trial of AIMSPRO(R)
8. Sunrise Biotech Holding Limited Application For Admission to PLUS
9. RoundTable Healthcare Partners Closes Sale of MedAssist Holding, Inc. to Firstsource Solutions Limited
10. Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results
11. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...a research industry first, allowing veterinary res...afety study data to be managed in one software app... NJ (PRWEB) November 9, 2009 -- Xybion Medical Sys...™ VM, an integrated enterprise software solu...d care of veterinary research subjects. Pristima&t...
(Date:11/8/2009)... Complete Genomics, a third-generation human genom...of a report in the journal Science describing it...nalysis of sequence data from three complete human...omes sequenced on the proof-of-principle genomic D...to $1,726 for 45x coverage for the samples describ...
(Date:11/6/2009)...tCall/ -- BioSpecifics Technologies Corp. (Nasdaq:...irst-in-class collagenase-based products, today an...r ended September 30, 2009. ,, "We were extrem...,s Arthritis Advisory Committee unanimously recomm...TM) for the treatment of Dupuytren,s disease, and ...
(Date:11/6/2009)...wire/ -- EUCODIS Bioscience, a company,developing,... for the,chemical industry announced today that it...dus, the leading biopharmaceutical company in Lati...Bioscience exclusive access - for the search,of en...ection of,psychrophilic bacteria strains and other...
Breaking Biology Technology:Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2
...in Shipping Dronabinol Soft Gel Capsules Immediate...ical Companies, Inc. (NYSE: PRX ) today announced... Food and Drug Administration for its,Abbreviated ...sion of,Solvay Pharmaceutical,s Marinol(R), a CIII... treat nausea and vomiting associated with cancer,...
...alif., June 30 As most doctors face the,Congressi...s next week,Arcadian Health Plan, Inc. announced t...network physicians at the same level of payment as...o supporting its physician,partners as they contin...,members., Arcadian recognizes the value and qual...
...H, Mass. June 30 Joseph B. Bolen, Ph.D., CSO,of M... Cancer track IBC,Life Sciences Drug Discovery & D...nd Exhibition taking place August 4-7 at the World.... The cancer track presentations will,focus on the...ncers, and,Clinical Biomarkers., Bolen has confir...
Other Biology Technology:Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules 2Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules 3Joseph B. Bolen, Ph.D. from Millennium to Conference Chair Cancer Sessions at IBC's Drug Discovery & Development of Innovative Therapeutics Conference 2
(Date:11/5/2009)... , The National Association of Biology Teachers (...or of biological sciences at Naugatuck Valley Comm...th the 2009 Evolution Education Award during the N...be held 11-14 November 2009 in Denver, Colorado. ,... the American Institute of Biological Sciences,(A...
(Date:11/4/2009)... , Heavy traffic corridors in the cities of Long ...ant proportion of preventable childhood asthma, an...ons on the disease has likely been underestimated,...thern California (USC). , The study, which appe...of Public Health , estimated that nine percent of ...
(Date:11/4/2009)... , PORTOLA VALLEY, Calif., Oct. 19 /PRNewswir...nced molecular sensing and imaging devices which s...today that it has signed exclusive distribution de...and Sensors. The markets covered include Australi...urg (Benelux), Suriname, Italy, France, Spain, Por...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2USC study finds big air pollution impacts on local communities 2Spectros Signs New International Distribution Deals 2Illinois Medical District Recognizes Officers of its District Security Group 47860 1Illinois Medical District Recognizes Officers of its District Security Group 47860 2Pharmaxis Announces Placement of 2447 Million and Share Purchase Plan 12459 1Pharmaxis Announces Placement of 2447 Million and Share Purchase Plan 12459 2Orlando Dermatology Aesthetic 26 Clinical 28ODAC 29 Conference Announces Its 2010 Event 47854 1Orlando Dermatology Aesthetic 26 Clinical 28ODAC 29 Conference Announces Its 2010 Event 47854 2
...ered that two microRNA (miRNA) molecules help cont...of B-cell chronic lymphocytic leukemia (B-CLL), th...r findings, published in the December 15 issue of ...ing as powerful regulators of gene expression in c... drug treatment, the investigators say. , In t...
...blem could be eliminated simply by dusting slag on...& Industry, the magazine of the SCI. , In the ...f damage annually. , Researcher David Cowen and...t applying slag to wheat growing in greenhouses ha...orporate the silica and express it as spiky struct...
... of plants to defend themselves by accumulating hi...me insects, and that such adaptation potentially e...ites may in turn evolve to deal with high levels o...zabeth Pilon-Smits of Colorado State University an...rnia, Berkeley, appear in the November 21st issue ...
Other Biology News:Pair of microRNA molecules controls major oncogene in most common leukemia 2New moth variety disarms plants guarded by selenium 2
...ystem - dUTP with CyScribe GFX Purification Kit, 5...f Cy3- and Cy5-labeled cDNA.Optimized reagents are...purification.Flexible and optimized protocols can ...her Cy3- or Cy5-labeled nucleotides.Reliable purif...
Canine serum from Equitech-Bio
Rabbit Anti-TOLLIP Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
... mA, 100 W maximum.Constant voltage, constant curr...ts in settings and read-outs for precision and rep...tstanding choice for non-IEF ultrathin flatbed gel...Electrophoresis Systems & Standards & Reagents, Po...
Biology Products: